Skip to main content

Table 2 Difference in dates of marketing approval and decisions about drug/indication between Canada and the United States

From: A comparison of the Food and Drug Administration’s and Health Canada’s regulatory decisions about failed confirmatory trials for oncology drugs: an observational study

Difference in approval dates for all 10 drug/indications (years, 95% CI)* Difference in decision dates about drug/indication for 5 drugs where both countries made decision (years, 95% CI)* Difference in decision dates about drug/indication for 4 drugs where US made a decision and Canada had not (years, 95% CI)*
0.92 (0.59, 1.24) 1.08 (− 1.55, 3.71) 0.29 (− 0.10, 0.67)
  1. *Time shorter in the US